Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cognitive disorders in multiple sclerosis].

B Brochet1, M Bonnet, M Deloire

  • 1Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33076 Bordeaux cedex, France. bruno.brochet@chu-bordeaux.fr

Revue Neurologique
|July 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach.

European journal of neurology·2026
Same author

Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.

Revue neurologique·2026
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Relationship between fecal egg counts and intestinal nematode burden of naturally infected dogs, derived from records of anthelmintic efficacy studies.

Veterinary parasitology·2025
Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025
Same author

Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA).

Journal of neurology·2024
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Cognitive dysfunction affects 40-60% of multiple sclerosis (MS) patients, worsening with disease progression. Early detection of cognitive deficits like impaired processing speed, attention, and memory is crucial.

Area of Science:

  • Neurology
  • Neuroscience
  • Cognitive Science

Context:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Cognitive dysfunction is a common but not fully understood complication in MS patients.
  • The progression and natural history of cognitive deficits in MS require further investigation.

Purpose:

  • To elucidate the prevalence and patterns of cognitive dysfunction across different clinical forms of Multiple Sclerosis.
  • To investigate the relationship between disease progression and the severity of cognitive impairments.
  • To explore the underlying neuropathological basis of cognitive deficits in MS.

Summary:

  • Cognitive dysfunction affects 40-60% of individuals with Multiple Sclerosis.
  • Impaired information processing speed, attention, and memory are most prevalent.

Related Experiment Videos

  • Cognitive deficits escalate with disease progression, from clinically isolated syndromes to progressive forms of MS.
  • Diffuse cerebral injury, identified via MRI, correlates with cognitive dysfunction by disrupting neural networks.

    • Impact:

    • Highlights the significant impact of cognitive dysfunction on the quality of life for MS patients.
    • Underscores the need for early screening and intervention strategies for cognitive impairments in MS.
    • Provides insights into the neuroanatomical underpinnings of cognitive decline in MS, guiding future research and therapeutic targets.